These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30797286)

  • 1. Metformin induced autophagy in diabetes mellitus - Tuberculosis co-infection patients: A case study.
    Novita BD; Ali M; Pranoto A; Soediono EI; Mertaniasih NM
    Indian J Tuberc; 2019 Jan; 66(1):64-69. PubMed ID: 30797286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin associated inflammation levels regulation in type 2 diabetes mellitus-tuberculosis coinfection patients - A case report.
    Novita BD; Soediono EI; Nugraha J
    Indian J Tuberc; 2018 Oct; 65(4):345-349. PubMed ID: 30522623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case risk study of lactic acidosis risk by metformin use in type 2 diabetes mellitus tuberculosis coinfection patients.
    Novita BD; Pranoto A; Wuryani ; Soediono EI; Mertaniasih NM
    Indian J Tuberc; 2018 Jul; 65(3):252-256. PubMed ID: 29933869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
    BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin: A review of its potential as enhancer for anti tuberculosis efficacy in diabetes mellitus-tuberculosis coinfection patients.
    Novita BD
    Indian J Tuberc; 2019 Apr; 66(2):294-298. PubMed ID: 31151499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of combined tuberculosis and diabetes.
    van Crevel R; Koesoemadinata R; Hill PC; Harries AD
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1404-1410. PubMed ID: 30606312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of metformin in diabetic patients with and without tuberculosis.
    Mary Rebecca Y; Sudha V; Bharathiraja T; Kannan T; Lavanya J; Hemanth Kumar AK
    Indian J Tuberc; 2023 Jan; 70(1):37-41. PubMed ID: 36740315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.
    Degner NR; Wang JY; Golub JE; Karakousis PC
    Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in tuberculosis: beyond control of hyperglycemia.
    Oglesby W; Kara AM; Granados H; Cervantes JL
    Infection; 2019 Oct; 47(5):697-702. PubMed ID: 31119504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
    Ma Y; Pang Y; Shu W; Liu YH; Ge QP; Du J; Li L; Gao WW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1259-1263. PubMed ID: 29679254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.
    Alfarisi O; Mave V; Gaikwad S; Sahasrabudhe T; Ramachandran G; Kumar H; Gupte N; Kulkarni V; Deshmukh S; Atre S; Raskar S; Lokhande R; Barthwal M; Kakrani A; Chon S; Gupta A; Golub JE; Dooley KE
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of tuberculosis].
    Ben Amar J; Dhahri B; Aouina H; Azzabi S; Baccar MA; El Gharbi L; Bouacha H
    Rev Pneumol Clin; 2015; 71(2-3):122-9. PubMed ID: 25434510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review.
    Yu X; Li L; Xia L; Feng X; Chen F; Cao S; Wei X
    BMC Infect Dis; 2019 Oct; 19(1):859. PubMed ID: 31623569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
    Davies GR; Connolly C; Sturm AW; McAdam KP; Wilkinson D
    AIDS; 1999 May; 13(7):811-7. PubMed ID: 10357380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.